A Phase 1, Open-Label, Single Dose, Bioavailability Study In Healthy Volunteers Comparing PF-05089771 TS Tablet To PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And The Fed State
Latest Information Update: 31 Mar 2012
Price :
$35 *
At a glance
- Drugs PF 5089771 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 31 Mar 2012 New trial record